about
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseNew Strategies for the Treatment of Solid Tumors with CAR-T CellsAnti-tumor immunity: myeloid leukocytes control the immune landscapeRational combinations of immunotherapeutics that target discrete pathways.In vivo discovery of immunotherapy targets in the tumour microenvironment.MicroRNA-150 modulates intracellular Ca 2+ levels in naïve CD8+ T cells by targeting TMEM20.A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumorsT-cell exhaustion: characteristics, causes and conversion.Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.Do γδ T cells predict osteonecrosis of the jaw?Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig.Mycobacterium tuberculosis secretory proteins downregulate T cell activation by interfering with proximal and downstream T cell signalling eventsA Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Egr2-dependent gene expression profiling and ChIP-Seq reveal novel biologic targets in T cell anergy.Role of diacylglycerol kinases in T cell development and function.Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4.Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.Costimulatory and coinhibitory receptors in anti-tumor immunityChloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness.Molecular mechanisms of T-cell tolerance.GIMAP Proteins in T-Lymphocytes.T-cell tolerance in cancer.PAG--a multipurpose transmembrane adaptor protein.Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy.Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian CarcinomaErosion of Transplantation Tolerance After Infection.DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy.IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset.Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus.Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy.Immune Regulation by Ubiquitin Tagging as Checkpoint Code.Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.Toxicity of cobalt-chromium nanoparticles released from a resurfacing hip implant and cobalt ions on primary human lymphocytes in vitro.
P2860
Q26744527-38BE97A6-60B8-4269-A1AD-6C7DE65B49D2Q26748500-9923E5C0-D26D-4C97-9829-208559007209Q28390573-4DB82BEF-713D-4525-995B-BAFFFF753BB0Q33606144-59F69F88-9F21-4E2A-A505-D43016FD232DQ33736396-56FF90B7-687F-4C78-8A93-F07D870FEADCQ33752767-69F6A955-9B8A-4CC7-A141-5E0FEC5D0CDFQ33769952-2A7F3C14-B2CD-4F9B-8D21-806823E39801Q33859997-9F2C324E-38D6-40D2-A22B-8FDBFC08E58AQ34052580-96797F35-E080-4D97-9CED-4462F4C62BB8Q34102010-356C29D6-B9A2-4740-8D6F-222DE7D49204Q34162136-AB63214B-5C2E-4E1D-BE06-B0EA77E569C7Q34749303-34CA87D8-392F-4900-9D99-A9B0A6177FB8Q34778932-0A179954-4B56-4F13-B2C1-490BB733A153Q35046087-9B0FF641-98F2-40BE-B0F3-873606904142Q35364372-68317F05-42AC-4FB1-AE0D-6D9C1B9FD914Q35836413-D687E454-1F90-4162-8E46-44E687D4FE66Q36709308-BF559E91-9380-4C41-9359-E0372693E1B7Q36823855-9E763A1C-F578-47DD-9880-D817D493A2B2Q36946379-D6E18184-0CAD-4568-88B6-6C9924CF0418Q37033673-FF79963C-E35C-4389-89AA-66F4DAC1C6CBQ37281626-34BFBEAE-9397-4529-8118-701A85586455Q37390890-FA4C3845-EFB4-4AD9-BC02-63F3A55A1211Q37474920-6F9180FF-A14A-45F9-BEA5-3B96D57D0514Q37627829-EE78BF71-386F-4CE5-9275-C844E5FC29B6Q37809578-12DB4E22-48D5-4FA0-97CA-E8526B1EBF26Q37864696-613C60CB-A568-4198-B207-D5BA6462388BQ37884387-A8638C00-8C03-4DA2-80ED-C0C248EE453CQ38103582-70F2D9E0-54F3-4231-98C9-A329E0A72150Q38161403-5EA69ED7-7FF1-422E-A677-1BDBC28D484EQ38526844-4D796CD0-AD56-43C3-8D9B-F1A7A7F592CAQ39196835-918B0E1A-ED1A-4CC5-A71C-B008D4AF3B9AQ39888120-5FF7B510-2C1F-4C3C-ADA9-68A511AEA1A1Q40641361-68ED6083-7A3D-41CA-81A0-EDB785D7361AQ41764893-1918F359-A7A0-4932-9C61-DC9D13E06552Q42141575-0E979E34-5E3A-41F1-9ACA-B2CBA71CEA29Q45928253-F37E26DF-039C-444F-87D8-29FDB2D9BCAFQ46694980-9959E4E4-5231-48FF-96AE-2777F4177ACEQ47774246-299102D4-C4D3-4D37-A959-300A13D33F75Q49592929-8E5DBB07-8F29-4285-9F20-7D7092219ED1Q50453204-6D213A72-5CB5-409E-8D0E-01A8536FF201
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Molecular regulation of T-cell anergy.
@ast
Molecular regulation of T-cell anergy.
@en
type
label
Molecular regulation of T-cell anergy.
@ast
Molecular regulation of T-cell anergy.
@en
prefLabel
Molecular regulation of T-cell anergy.
@ast
Molecular regulation of T-cell anergy.
@en
P2093
P2860
P356
P1433
P1476
Molecular regulation of T-cell anergy.
@en
P2093
Thomas F Gajewski
Yuanyuan Zha
P2860
P356
10.1038/SJ.EMBOR.7401138
P577
2008-01-01T00:00:00Z